S
Savara D
D
SVRA
2.14000
USD
-0.05
(-2.06%)
مفتوح الان
حجم التداول
729
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
369,871,013
الأخبار المقالات
العنوان: Savara
القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.